Therapeutic drug monitoring for oral anticancer drugs in clinical routine: The ON-TARGET study

被引:0
|
作者
Mc Laughlin, A. [1 ,2 ]
Schmulenson, E. [3 ]
Teplytska, O. [3 ]
Zimmermann, S. [4 ]
Opitz, P. [5 ]
Groenland, S. L. [6 ]
Huitema, A. [7 ,8 ]
Steeghs, N. [6 ]
Mueller, L. [9 ]
Fuxius, S.
Joerger, M. [10 ]
Mayer, F. [11 ]
Fuhr, U. [12 ,13 ]
Holdenrieder, S. [14 ]
Hempel, G. [5 ]
Scherf-Clavel, O. [4 ]
Mikus, G. [1 ,3 ]
Jaehde, U. [3 ]
Kloft, C. [1 ]
机构
[1] Free Univ Berlin, Inst Pharm, Abt Klin Pharm & Biochem, Berlin, Germany
[2] Grad Res Training Program PharMetrX, Berlin, Germany
[3] Univ Bonn, Inst Pharm, Dept Clin Pharm, Bonn, Germany
[4] Julius Maximilians Univ Wurzburg, Inst Pharm & Food Chem, Wurzburg, Germany
[5] Univ Munster, Dept Pharmaceut & Med Chem Clin Pharm, Munster, Germany
[6] Netherlands Canc Inst, Div Med Oncol, Dept Clin Pharmacol, Amsterdam, Netherlands
[7] Netherlands Canc Inst, Dept Pharm & Pharmacol, Amsterdam, Netherlands
[8] Univ Utrecht, Univ Med Ctr, Dept Clin Pharm, Utrecht, Netherlands
[9] Onkol UnterEms, Leer, Germany
[10] Cantonal Hosp St Gallen, Dept Med Oncol & Hematol, St Gallen, Switzerland
[11] Prof Dr Helmut Oettle & Prof Dr Dr Frank Mayer, Praxis & Tagesklin, Friedrichshafen, Germany
[12] Univ Cologne, Fac Med, Cologne, Germany
[13] Univ Hosp Cologne, Ctr Pharmacol, Dept Pharmacol 1, Cologne, Germany
[14] Tech Univ Munich, Inst Lab Med, German Heart Ctr Munich, Munich, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
V19
引用
收藏
页码:50 / 50
页数:1
相关论文
共 50 条
  • [1] Developing a Nationwide Infrastructure for Therapeutic Drug Monitoring of Targeted Oral Anticancer Drugs: The ON-TARGET Study Protocol
    Mc Laughlin, Anna M.
    Schmulenson, Eduard
    Teplytska, Olga
    Zimmermann, Sebastian
    Opitz, Patrick
    Groenland, Stefanie L.
    Huitema, Alwin D. R.
    Steeghs, Neeltje
    Mueller, Lothar
    Fuxius, Stefan
    Illerhaus, Gerald
    Joerger, Markus
    Mayer, Frank
    Fuhr, Uwe
    Holdenrieder, Stefan
    Hempel, Georg
    Scherf-Clavel, Oliver
    Jaehde, Ulrich
    Kloft, Charlotte
    CANCERS, 2021, 13 (24)
  • [2] Therapeutic Drug Monitoring for oral tumor Therapeutics in clinical Routine: First Results of the ON-TARGET Study
    Teplytska, O.
    Klima, F.
    McLaughlin, A.
    Stapf, M.
    Opitz, P.
    Muller, L.
    Fuxius, S.
    Joerger, M.
    Schmulenson, E.
    Zimmermann, S.
    Hempel, G.
    Scherf-Clavel, O.
    Jaehde, U.
    Kloft, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 109 - 110
  • [3] Therapeutic drug monitoring of oral anticancer drugs - preliminary results of a prospective study
    Groenland, S. L.
    Van Eerden, R. A. G.
    Koolen, S. L.
    Moes, D. J. A. R.
    Desar, I. M. E.
    Touw, D. J.
    Imholz, A. L. T.
    Reyners, A. K. L.
    Gelderblom, H.
    van Erp, N. P.
    Mathijssen, R. H. J.
    Huitema, A. D. R.
    Steeghs, N.
    ANNALS OF ONCOLOGY, 2019, 30
  • [4] Application of pharmacokinetic modelling to the routine therapeutic drug monitoring of anticancer drugs
    Rousseau, A
    Marquet, P
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2002, 16 (04) : 253 - 262
  • [5] Therapeutic Drug Monitoring of Oral Anticancer Drugs: The Dutch Pharmacology Oncology Group-Therapeutic Drug Monitoring Protocol for a Prospective Study
    Groenland, Stefanie L.
    van Eerden, Ruben A. G.
    Verheijen, Remy B.
    Koolen, Stijn L. W.
    Moes, Dirk Jan A. R.
    Desar, Ingrid M. E.
    Reyners, Anna K. L.
    Gelderblom, Hans J.
    van Erp, Nielka P.
    Mathijssen, Ron H. J.
    Huitema, Alwin D. R.
    Steeghs, Neeltje
    THERAPEUTIC DRUG MONITORING, 2019, 41 (05) : 561 - 567
  • [6] Rationale for therapeutic drug monitoring (TDM) of anticancer drugs
    Boddy, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2001, 15 : 8 - 8
  • [7] Therapeutic drug monitoring of oral targeted antineoplastic drugs
    Anna Mueller-Schoell
    Stefanie L. Groenland
    Oliver Scherf-Clavel
    Madelé van Dyk
    Wilhelm Huisinga
    Robin Michelet
    Ulrich Jaehde
    Neeltje Steeghs
    Alwin D.R. Huitema
    Charlotte Kloft
    European Journal of Clinical Pharmacology, 2021, 77 : 441 - 464
  • [8] Therapeutic drug monitoring of oral targeted antineoplastic drugs
    Mueller-Schoell, Anna
    Groenland, Stefanie L.
    Scherf-Clavel, Oliver
    van Dyk, Madele
    Huisinga, Wilhelm
    Michelet, Robin
    Jaehde, Ulrich
    Steeghs, Neeltje
    Huitema, Alwin D. R.
    Kloft, Charlotte
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (04) : 441 - 464
  • [9] Evaluation of Extrapolation Methods to Predict Trough Concentrations to Guide Therapeutic Drug Monitoring of Oral Anticancer Drugs
    Janssen, Julie M.
    Dorlo, Thomas P. C.
    Beijnen, Jos H.
    Huitema, Alwin D. R.
    THERAPEUTIC DRUG MONITORING, 2020, 42 (04) : 532 - 539
  • [10] Therapeutic Drug Monitoring of Targeted Anticancer Protein Kinase Inhibitors in Routine Clinical Use: A Critical Review
    Cardoso, Evelina
    Guidi, Monia
    Blanchet, Benoit
    Schneider, Marie Paule
    Decosterd, Laurent A.
    Buclin, Thierry
    Csajka, Chantal
    Widmer, Nicolas
    THERAPEUTIC DRUG MONITORING, 2020, 42 (01) : 33 - 44